Overview

A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)

Status:
Completed

Trial end date:
2012-06-01

Target enrollment:

Participant gender:

Summary

This randomized, parallel-group, open-label study will evaluate the effect of Actemra (tocilizumab) on vaccination in patients with active rheumatoid arthritis who have an inadequate response to methotrexate and who have had an inadequate clinical response or were intolerant to treatment with one or more anti-tumor necrosis factor (anti-TNF) therapies.

Phase:

Phase 4

Details

Lead Sponsor:

Genentech, Inc.

Treatments:

Heptavalent Pneumococcal Conjugate Vaccine
Methotrexate
Vaccines